|Bid||16.32 x 800|
|Ask||17.23 x 1100|
|Day's range||16.23 - 17.09|
|52-week range||5.90 - 29.27|
|Beta (5Y monthly)||3.62|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2020 - 10 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Oct 2018|
|1y target est||15.50|
Adient (ADNT) scraps 2020 guidance as management expects the coronavirus pandemic and related setbacks to strain its operations in the days to come.
Adient (ADNT) delivered earnings and revenue surprises of 93.75% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adient (ADNT) anticipates 2020 adjusted EBITDA to be dented by COVID-19 and track toward the lower end of the outlook of $870-$910 million.
While an extensive array of value-added products is aiding Superior Industries' (SUP), elevated debt and reduced sales outlook are concerns.
AutoZone's (AZO) domestic commercial sales totaled $556.9 million in second-quarter fiscal 2020, up from the $514.6 million recorded in the year-ago quarter.
While Toyota (TM) steers $400 million to self driving startup Pony.ai, Adient (ADNT) narrows its 2020 view amid coronavirus concerns.
Adient (ADNT) anticipates equity income to be down $175-$185 million in 2020 compared with the prior estimate of $235-$245 million amid the Coronavirus outbreak.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.